Skip to content

Author

H. Dauerman

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Temporal Trends in Transcatheter Tricuspid Valve Interventions After FDA Approval in the United States

Background Transcatheter tricuspid valve interventions (TTVIs) have recently received commercial approval; however, contemporary adoption trends in early postapproval phase are not well described. Objectives The objectives of the study were to characterize trends in utilization of transcatheter tricuspid edge-to-edge r...

Bharat Rawlley, Maximilian Reisinger, Hannah R. Murphy et al. · 0 citations
Open access Aug 2026

Redo-Transcatheter Aortic Valve Replacement With Self-Expanding Valves: A U.S. Registry Analysis.

In a national registry, redo-TAVR with the Evolut platform was associated with low procedural complication rates and clinical outcomes comparable with those observed with native TAVR and support redo-TAVR with Evolut as a feasible and effective treatment strategy in appropriately selected patients.

Toby Rogers, V. Bapat, S. Chetcuti et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.